Literature DB >> 2084127

Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column.

S Menzel-Soglowek1, G Geisslinger, K Brune.   

Abstract

The effect of mobile phase composition, pH and temperature on the chiral resolution and retention of some 2-arylpropionic acids using the chiral alpha 1-acid glycoprotein column EnantioPac is described. Furthermore, a direct stereoselective high-performance liquid chromatographic assay to determine the enantiomers of ketoprofen, ibuprofen and fenoprofen in plasma is presented. Detection was at 260, 220 and 220 nm for ketoprofen, ibuprofen and fenoprofen, respectively. The limit of detection was 0.1 micrograms/ml for the enantiomers of ketoprofen and ibuprofen, and 0.25 micrograms/ml for the enantiomers of fenoprofen. The method was demonstrated to be applicable for stereoselective pharmacokinetic studies of ketoprofen, ibuprofen and fenoprofen after administration under clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084127     DOI: 10.1016/s0378-4347(00)83780-9

Source DB:  PubMed          Journal:  J Chromatogr


  11 in total

1.  Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.

Authors:  Ville-Veikko Hynninen; Klaus T Olkkola; Kari Leino; Stefan Lundgren; Pertti J Neuvonen; Anders Rane; Mika Valtonen; Hanna Vyyryläinen; Kari Laine
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats.

Authors:  C J Meunier; R K Verbeeck
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of dexketoprofen.

Authors:  M J Barbanoj; R M Antonijoan; I Gich
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition.

Authors:  K Brune; W S Beck; G Geisslinger; S Menzel-Soglowek; B M Peskar; B A Peskar
Journal:  Experientia       Date:  1991-03-15

Review 5.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

6.  Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.

Authors:  J Lötsch; U Muth-Selbach; I Tegeder; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

7.  Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.

Authors:  Aleksi Tornio; Mikko Niemi; Pertti J Neuvonen; Janne T Backman
Journal:  Eur J Clin Pharmacol       Date:  2007-02-27       Impact factor: 2.953

8.  Pharmacokinetics of ketoprofen enantiomers after different doses of the racemate.

Authors:  G Geisslinger; S Menzel; K Wissel; K Brune
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

Review 9.  Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.

Authors:  Ashish Singh; Pratibha Tripathi; Sarika Singh
Journal:  Inflammopharmacology       Date:  2020-10-14       Impact factor: 4.473

10.  Stereoselective enzymatic hydrolysis of various ester prodrugs of ibuprofen and flurbiprofen in human plasma.

Authors:  N Mørk; H Bundgaard
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.